LEV PHARMACEUTICALS
Lev Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Its products include C1-INH that is used for the treatment of hereditary angioedema. The company was founded in 2003 and is based in New York, New York. As of October 21, 2008, Lev Pharmaceuticals, Inc. operates as a subsidiary of ViroPharma Inc.
LEV PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
New York, New York, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
41 M USD
Similar Organizations
Resolvyx Pharmaceuticals
Resolvyx Pharmaceuticals develops therapeutics with small molecule lipid mediators for the treatment of inflammatory diseases.
Current Employees Featured
Founder
Investors List
Mast Capital Management
Mast Capital Management investment in Venture Round - Lev Pharmaceuticals
Alexandra Investment Management
Alexandra Investment Management investment in Venture Round - Lev Pharmaceuticals
Rosalind Capital Partners
Rosalind Capital Partners investment in Venture Round - Lev Pharmaceuticals
Emigrant Capital
Emigrant Capital investment in Venture Round - Lev Pharmaceuticals
Southpoint Capital Advisors
Southpoint Capital Advisors investment in Venture Round - Lev Pharmaceuticals
Hound Partners
Hound Partners investment in Venture Round - Lev Pharmaceuticals
More informations about "Lev Pharmaceuticals"
Lev Pharmaceuticals 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, investors, and executives for Lev Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
ViroPharma To Acquire Lev Pharmaceuticals - Fierce Biotech
Jul 15, 2008 The acquisition of Lev Pharmaceuticals further enhances ViroPharma's pipeline with Cinryze (TM) (C1 inhibitor (human)), which is currently under regulatory review for โฆSee details»
Lev Pharmaceuticals - Ownership and Business Overview - Mergr
Oct 21, 2008 Lev Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases.See details»
Lev Pharmaceuticals - Funding, Financials, Valuation & Investors
Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.See details»
Lev Pharmaceuticals - Products, Competitors, Financials, โฆ
Lev Pharmaceuticals was a Healthcare/Pharmaceuticals / Drugs company based in New York, New York. Use the CB Insights Platform to explore Lev Pharmaceuticals's full profile.See details»
Lev Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Lev Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Immune System Diseases, Technology Platform ...See details»
Lev Pharmaceuticals, Inc. (Lev Pharmaceuticals, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
May 1, 2023 About Lev Pharmaceuticals, Inc. Lev is a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases.See details»
Lev Pharmaceuticals, Inc.:Company Profile & Technical Research ...
Lev Pharmaceuticals is a company that provides Medicine, Pharmacy and Therapeutics, Hereditary angioedema and more. Lev Pharmaceuticals is headquartered in United States โฆSee details»
Joshua Schein - CEO - Lev Pharmaceuticals | LinkedIn
CEO at Lev Pharmaceuticals · Experience: Lev Pharmaceuticals · Location: New York. View Joshua Scheinโs profile on LinkedIn, a professional community of 1 billion members.See details»
ViroPharma To Acquire Lev Pharmaceuticals
Jul 16, 2008 ViroPharma Incorporated and Lev Pharmaceuticals, Inc. recently announced that the companies have signed a definitive merger agreement under which ViroPharma will โฆSee details»
ViroPharma Inc. (VPHM) and Lev Pharmaceuticals Inc. (LEVP.OB) โฆ
Jul 15, 2008 Biopharmaceutical companies ViroPharma Inc. (Nasdaq: VPHM) and Lev Pharmaceuticals Inc. (OTCBB: LEVP) today announced a definitive merger agreement โฆSee details»
ViroPharma Incorporated Completes Acquisition Of Lev โฆ
Oct 24, 2008 ViroPharma Incorporated recently announced it has completed its acquisition of Lev Pharmaceuticals following the approval earlier today of the transaction by Lev stockholders.See details»
Lev Pharmaceuticals Company Profile | Management and
Find contact information for Lev Pharmaceuticals. Learn about their Drug Stores & Pharmacies, Retail market share, competitors, and Lev Pharmaceuticals's email format.See details»
ViroPharma to buy Lev for $442M | Fierce Biotech
Jul 15, 2008 ViroPharma has forged a deal to buy Lev Pharmaceuticals - a developer focused on developing inflammatory therapies -- for $442 million. The deal provides ViroPharma with โฆSee details»
Lev Pharmaceuticals - Overview, News & Similar companies
View Lev Pharmaceuticals (www.levpharm.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
What is Lev Pharmaceuticals? Company Culture, Mission, Values
See what employees say it's like to work at Lev Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at Lev Pharmaceuticals.See details»
Lev Pharmaceuticals - Crunchbase
Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.See details»
Paladin Pharma and the pan-Canadian Pharmaceutical Alliance โฆ
56 minutes ago Paladin Pharma Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical โฆSee details»
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense ...
Mar 10, 2025 Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Companyโs Single-Dose Mpox and Smallpox โฆSee details»
Lev Pharmaceuticals - Contacts, Employees, Board Members
Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.See details»